Drug REpurposing with Artificial intelligence for Muscular disorderS

Project Information

DREAMS

Grant agreement ID: 101080229

DOI

10.3030/101080229

EC signature date 8 October 2023

Start date 1 November 2023

End date 31 October 2028

Funded under

Health

Total cost

€ 6 952 110,00

EU contribution

€ 6 952 110,00

6 952 110,00

Coordinated by

CENTRE D'ETUDE DES CELLULES SOUCHES
France

News

Scientific advances

Speeding up hope for rare neuromuscular diseases

13 October 2026

Scientific advances

Accelerating discovery of novel treatments for rare diseases

6 February 2026

Download Download the content of the page

XML

Last update: 23 September 2026

Permalink: https://cordis.europa.eu/project/id/101080229/news

European Union, 2026